People with high cholesterol can reduce the risk of a first time heart attack by 31 per cent and the risk or death by 22 per cent by takIng a widely prescribed drug tailed pravastatin sodium. This was the conclusion ofa landmark study in the UK -the West of Scotland Coronary Prevention Study - presented at the annual meeting of the American Heart Association. In the study, conducted by the University of Glasgowand funded by Bristol-Myers Squibb Pharmaceuticals, nearly one-third of expected heart attacks were avoided in the pravastatin-treated patients.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.